| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,481 |
5,380 |
$893K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,599 |
4,178 |
$857K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,709 |
1,957 |
$522K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,206 |
1,916 |
$189K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,593 |
2,878 |
$159K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,661 |
1,303 |
$138K |
| 87428 |
|
2,454 |
2,074 |
$123K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,009 |
142 |
$116K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,677 |
2,786 |
$78K |
| 71046 |
Radiologic examination, chest; 2 views |
1,674 |
1,416 |
$64K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,482 |
3,926 |
$59K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,442 |
1,925 |
$50K |
| 71045 |
Radiologic examination, chest; single view |
1,608 |
1,243 |
$49K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
572 |
445 |
$48K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,169 |
1,018 |
$36K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,010 |
5,281 |
$35K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,241 |
905 |
$35K |
| 80053 |
Comprehensive metabolic panel |
5,161 |
3,979 |
$34K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
487 |
448 |
$33K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
356 |
261 |
$32K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
934 |
827 |
$32K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
908 |
653 |
$32K |
| 70450 |
Computed tomography, head or brain; without contrast material |
218 |
187 |
$19K |
| Q3014 |
Telehealth originating site facility fee |
989 |
825 |
$18K |
| 74018 |
|
253 |
207 |
$11K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
385 |
364 |
$11K |
| 83880 |
|
615 |
466 |
$11K |
| 81025 |
|
1,675 |
1,441 |
$11K |
| 84484 |
|
1,648 |
1,140 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
5,257 |
3,907 |
$10K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
165 |
138 |
$9K |
| 81001 |
|
3,445 |
2,894 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
955 |
712 |
$6K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
25 |
19 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
786 |
631 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
357 |
335 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
57 |
13 |
$3K |
| 87807 |
|
285 |
256 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
18 |
13 |
$3K |
| 81003 |
|
1,688 |
1,435 |
$3K |
| 73560 |
|
55 |
50 |
$2K |
| 87077 |
|
410 |
303 |
$2K |
| 87186 |
|
374 |
275 |
$2K |
| 80305 |
|
186 |
157 |
$2K |
| 73630 |
|
35 |
26 |
$1K |
| 87634 |
|
14 |
14 |
$884.52 |
| 87088 |
|
136 |
107 |
$881.52 |
| 83690 |
|
162 |
137 |
$857.48 |
| 73030 |
|
17 |
13 |
$654.00 |
| 83605 |
|
173 |
111 |
$610.83 |
| 83735 |
|
364 |
248 |
$588.39 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,566 |
1,272 |
$356.84 |
| 84443 |
Thyroid stimulating hormone (TSH) |
32 |
26 |
$352.29 |
| 82553 |
|
27 |
26 |
$272.83 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
105 |
80 |
$187.67 |
| 94761 |
|
99 |
46 |
$138.49 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,098 |
856 |
$131.51 |
| 82962 |
|
35 |
12 |
$35.40 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
377 |
289 |
$7.44 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
251 |
202 |
$5.28 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
1,391 |
925 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
28 |
24 |
$0.00 |
| J3490 |
Unclassified drugs |
1,415 |
964 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
53 |
36 |
$0.00 |